Trial intelligence / Profile preview

Levocetirizine vs Cetirizine Sedation in Allergic Rhinitis

NCT00826943Phase 4Completed

Sponsor
Vanderbilt University
Start
Jan 2009
Primary completion
May 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of levocetirizine in allergic rhinitis (AR), sponsored by Vanderbilt University. Started Jan 2009; status: completed.

02

Drugs

levocetirizine
03

Conditions

allergic rhinitis (AR)

Beyond the preview

Go deeper on NCT00826943.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00826943.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call